Mechanism of cell death in experimental models of Parkinson's disease

Functional Neurology

Volumn 15, Issue 4, 2000, Pages 229-237

  Hirsch, E C ^a   Hunot, S ^a   Hartmann, A ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Apoptosis; Cytokine; Dopamine neuron; Glial cells; Nitric oxide

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CALBINDIN; CASPASE; CASPASE 3; CASPASE 8; CD23 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NEUROMELANIN; NITRIC OXIDE; OXYGEN RADICAL; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TYROSINE;

APOPTOSIS; CELL DEATH; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; GLIA CELL; INFLAMMATION; NERVE CELL DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; SUBSTANTIA NIGRA;

ANIMALS; APOPTOSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CAUDATE NUCLEUS; CELL COUNT; DISEASE MODELS, ANIMAL; INTERLEUKINS; MICE; NERVE DEGENERATION; NEUROGLIA; NITRIC OXIDE; PARKINSON DISEASE; RATS; RECEPTORS, DOPAMINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034495155     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
2. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease
3. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
4. Epidemiology of Parkinson's disease
5. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
6. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
7. Preservation of hypothalamic dopaminergic neurons in Parkinson's disease
8. The substantia nigra of the human brain - I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D-28k immunohistochemistry
9. The substantia nigra of the human brain - II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
10. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
11. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-in-toxicated monkeys: Effect of L-DOPA and GM1 ganglioside therapy
12. Glutathione peroxidase, glial cells and Parkinson's disease
13. Ageing and Parkinson's disease: Substantia nigra regional selectivity
14. Expression of calbindin D28K-like immuno-reactivity in catecholaminergic cell groups of the human midbrain: Normal distribution in Parkinson's disease
15. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: Sparing of calbindin-D28K-containing cells
16. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys
17. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
18. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease
19. Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra
20. GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons
21. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
22. Fc(epsilon) RII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells
23. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients
24. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevanted in the brain from parkinsonian patients
25. Increase in level of tumor necrosis factor (TNF)-alpha in 6-hydroxydopamine-lesioned striatum in rats without influence of systemic L-DOPA on the TNF-alpha induction
26. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
27. Expression, structure, and function of the CD23 antigen
28. Nitric oxide production by human monocytes: Evidence for a role of CD23
29. Involvement of Fc(epsilon)RII/CD23 and L-arginine dependent pathway in IgE-mediated activation of human eosinophils
30. Involvement of Fc epsilon RII/CD23 and L-arginine-dependent pathway in IgE-mediated stimulation of human monocyte function
31. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons
32. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
33. + induced substantia nigra degeneration is attenuated in nNOS knockout mice
34. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
35. Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease
36. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
37. Protein nitration in Parkinson's disease
38. Blood vessels change in the mesencephalon of patients with Parkinson's disease
39. Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling
40. FADD and caspase-8 are effectors in apoptotic death of dopaminergic neurons in Parkinson's disease but pathway inhibition results in neuronal necrosis
41. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
42. Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice
43. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining
44. Parkinson's disease: The apoptosis hypothesis revisited
45. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium-and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures
46. Glial cells mediate toxicity in gluthatione-depleted mesencephalic cultures